ENANTA PHARMACEUTICALS, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $11.3M | $281.3M | $16.6M |
| FY2017 | $25.0M | $326.6M | $65.7M |
| FY2018 | $20.5M | $414.2M | $63.9M |
| FY2019 | $27.3M | $489.8M | $51.2M |
| FY2020 | $30.6M | $486.1M | $87.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $11.3M | $281.3M | $16.6M |
| FY2017 | $25.0M | $326.6M | $65.7M |
| FY2018 | $20.5M | $414.2M | $63.9M |
| FY2019 | $27.3M | $489.8M | $51.2M |
| FY2020 | $30.6M | $486.1M | $87.1M |